Complication Rates and the Benefits of Neuraxial Anesthesia in the Patient With High Comorbidity Burden Undergoing Primary Total Joint Arthroplasty.

Abstract

The American Society of Anesthesiologists physical status classification 4 (ASA PS 4) comprises patients with "severe systemic disease that is a constant threat to life." The purpose of this study is to conduct a retrospective analysis to report the rate of complications in the ASA PS 4 patients who undergo elective total joint arthroplasty (TJA). In addition, we report whether neuraxial anesthesia is associated with improved outcomes compared to general anesthesia in these patients. The American College of Surgeons National Surgical Quality Improvement Program registry was used to extract patient records. The study population included patients aged ≥18 years who underwent TJA from 2014 to 2016 and who were classified as ASA PS 4. To measure differences in outcomes and patient characteristics, we used chi-squared tests. Odds ratios (ORs) and their 95% confidence intervals (CIs) were reported for all covariates. A P value of <.01 was selected. Among the patients who were ASA PS 4, 58 (1.4%) experienced 30-day mortality, 349 (8.2%) experienced 30-day readmission, 271 (6.3%) had a postoperative complication, and 504 (11.8%) required a transfusion. Those receiving neuraxial anesthesia compared to general anesthesia had lower odds of 30-day mortality (OR, 0.24; 95% CI, 0.12-0.49; P = .0001) and lower odds of perioperative transfusion (OR, 0.53; 95% CI 0.45-0.65; P < .0001). The elevated risks for ASA PS 4 patients undergoing TJA may be too high to justify surgery. Neuraxial anesthesia is a reasonable alternative to general anesthesia if pursuing TJA in patients with a very high comorbidity burden.